,i  #aaf? ,,congress  #a/ ,session  ,h4 
,r4 #ecch  ,,9 ,,! ,,h\se ,,(           
,,repres5tatives  ,decemb] #f1 #bjai,mr4
 ,mc,caul 7= himself & ,mr4 ,engel7     
introduc$ ! foll[+ bill2 :i* 0 ref]r$ to
 ! ,committee on ,=eign ,affairs  ,a    
,,bill  ,to au?orize ! ,secret>y ( ,/ate
 to pursue public-private p>tn]%ips1    
innovative f9anc+ me*anisms1 rese>*     
p>tn]%ips1 & coord9ation ) int]national 
& multilat]al organizations to address  
*ildhood canc] globally1 & = o!r        
purposes4  #a4 ,%ort title ,?is ,act may
 be cit$ z ! ,global ,hope ,act ( #bjai4
  #b4 ,f9d+s ,congress f9ds ! foll[+3   
7#a7 ,canc] is a lead+ cause ( dea? =   
*ildr5 & adolesc5ts ar\nd ! _w1 &       
approximately #cjj1jjj *ildr5 ag$ #j to 
#ai ye>s old are diagnos$ ) canc] ea*   
ye>4  7#b7 ,! mo/ common categories (   
*ildhood canc]s include leukemia1 bra9  
canc]1 lymphoma1 & solid tumors1 su* z  
neurobla/oma & ,wilms tumor4  7#c7 ,mo/ 
*ildhood canc]s c be cur$ ) g5]ic       
m$ic9es & c be co/-effective = all      

income levels4  7#d7 ,9 ! ,unit$ ,/ates1
 ! survival rate = *ildr5 diagnos$ )    
canc] is ov] #hj p]c5t4 ,9 _m develop+  
c\ntries1 ! mortality rate ( *ildr5     
diagnos$ ) canc] is ar\nd #hj p]c5t4 ,9 
"s p>ts ( ,africa1 ! mortality rate     
rea*es #ij p]c5t4  7#e7 ,9 ,septemb]    
#bjah1 ! ,_w ,heal? ,organization       
ann\nc$ a new ef=t--! ,global           
,initiative = ,*ildhood ,canc]--) ! aim 
( rea*+ at lea/ a #fj-p]c5t survival    
rate = *ildr5 ) canc] by #bjcj1 !reby   
sav+ an additional #a1jjj1jjj lives4    
#c4 ,s5se ( ,congress ,x is ! s5se (    
,congress z foll[s3 7#a7 ,! "w ( !      
,unit$ ,/ates on infecti\s disease      
rema9s ! core t5et ( ,unit$ ,/ates "w on
 global heal?4  7#b7 ,z ! ,unit$ ,/ates 
& int]national p>tn]s cont9ue to succe$ 
9 l[]+ incid5ces ( infecti\s diseases1  
global mortality rates (                
non-communicable diseases w become an   
increas+ burd5 t mu/ be address$4  7#c7 
,! ,unit$ ,/ates %\ld "w to support !   
goals ( ! ,_w ,heal? ,organization      

,initiative = ,*ildhood ,canc]1 help+   
increase survival rates = *ildr5 )      
canc]4  #d4 ,/atem5t ( policy ,! ,unit$ 
,/ates %all seek to-- 7#a7 increase     
political commitm5t = *ildhood canc]    
diagnosis1 treatm5t1 & c>e globally2    
7#b7 support ef=ts to increase !        
survival rate ( *ildr5 ) canc] globally2
  7#c7 support ef=ts to tra9 m$ical     
p]sonnel & develop ! capabilities ( o!r 
exi/+ heal?c>e infra/ructure to         
diagnose1 treat1 & c>e = *ildhood canc]2
  7#d7 improve access to af=dable &     
ess5tial m$ic9es & te*nologies t treat  
*ildhood canc]2  7#e7 elevate &         
prioritize ef=ts to r$uce ! mortality   
rate ( *ildhood canc] 9 int]national    
organizations su* z ! ,unit$ ,nations2  
7#f7 pursue rese>* & rese>* p>tn]%ips ) 
int]national in/itutions to id5tify     
l[-co/ int]v5tions & be/ practices to   
diagnose1 treat1 & c>e = *ildhood canc] 
globally2 &  7#g7 improve p>tn]%ips )   
int]national heal? m9i/ries &           
ph>maceutical companies to facilitate   

ef=ts = broad]1 global cl9ical trials = 
m$ic9es to treat or c>e = *ildhood      
canc]4  #e4 ,au?orization ,! ,secret>y (
 ,/ate1 9 coord9ation ) ! heads (       
relevant ,f$]al dep>tm5ts & ag5cies1 is 
au?oriz$ & enc\rag$ to--  7#a7 pursue   
public-private p>tn]%ips1 o!r rese>*    
p>tn]%ips1 & innovative f9anc+ me*anisms
 to address *ildhood canc] globally2 &  
7#b7 coord9ate ) appropriate ag5cies ( !
 ,unit$ ,nations & o!r relevant         
multilat]al organizations to address    
*ildhood canc] globally4  #f4 ,report ,n
 lat] ?an #a ye> aft] ! date ( !        
enactm5t ( ?is ,act1 ! ,secret>y ( ,/ate
 %all submit to ! ,committee on ,=eign  
,affairs ( ! ,h\se ( ,repres5tatives & !
 ,committee on ,=eign ,relations ( !    
,s5ate a report t includes ! foll[+3    
7#a7 ,an assessm5t ( opportunities =    
,unit$ ,/ates engagem5t 9 global ef=ts  
to increase ! worldwide survival rate ( 
*ildr5 ) canc]4  7#b7 ,an assessm5t (   
ef=ts tak5 by ! ,unit$ ,/ates to support
 ef=ts to increase ! worldwide survival 

rate ( *ildr5 ) canc]4  7#c7 ,an        
assessm5t ( exi/+ programs fund$ by !   
,unit$ ,/ates t c\ld be exp&$ to support
 ef=ts to increase ! worldwide survival 
rate ( *ildr5 ) canc]4  7#d7 ,an        
assessm5t ( h[ su* increas$ int]national
 engagem5t c\ld positively affect-- 7,a7
 survival rates ( individuals ) *ildhood
 canc] 9 ! ,unit$ ,/ates2 &  7,b7       
r$uctions 9 ! rates ( infant & p$iatric 
morbidity & mortality4  #g4 ,co/        
limitation ,no additional funds are     
au?oriz$ to be appropriat$ to c>ry out !
 provisions ( ?is ,act4  #h4 ,*ildhood  
canc] def9$ ,9 ?is ,act1 ! t]m *ildhood 
canc] means canc]s =m$ or diagnos$ 9    
individuals "u ! age ( #bj4